Hypersomnia Therapeutics Market to Grow Rapidly Owing to Novel...

adicionou um novo artigo Health

2025-04-30 12:28:24 -

Hypersomnia Therapeutics Market to Grow Rapidly Owing to Novel Orexin Agonists

Hypersomnia therapeutics encompass a range of pharmacological products designed to alleviate excessive daytime sleepiness associated with conditions such as idiopathic hypersomnia, narcolepsy type 2, and residual sleepiness following sleep apnea treatment. Key offerings include wake-promoting stimulants (e.g., modafinil, solriamfetol), histamine H3 receptor antagonists, and emerging orexin...

0 Comentários 0 Compartilhamentos 819 Visualizações 0 Anterior